A natural killer cell mimic against intracellular pathogen infections

Area of Science:

• Microbiology
• Immunology
• Biomedical Engineering

Background:

• Intracellular bacteria, like Staphylococcus aureus, evade host defenses and antibiotics by residing within host cells.
• This intracellular survival leads to persistent infections, treatment failures, and relapses, posing a significant clinical challenge.

Purpose of the Study:

• To develop and evaluate a novel cell-mimicking therapeutic strategy for eliminating intracellular Staphylococcus aureus.
• To demonstrate the efficacy of these therapeutics against vancomycin-resistant intracellular S. aureus.

Main Methods:

• Development of cell mimics incorporating a redox-responsive degradable carrier loaded with perforin and granzyme B.
• Testing the efficacy of these natural killer cell-mimics (NKMs) against intracellular S. aureus in vitro.
• Comparison of NKM therapeutic activity against vancomycin treatment.

Main Results:

• Intracellular Staphylococcus aureus, even in the presence of vancomycin, was effectively eliminated by the developed NKMs.
• The cell-mimicking therapeutics demonstrated superior efficacy compared to conventional clinical antibiotics.
• The study provides evidence for an NK cell-mimicking immune mechanism in treating intracellular S. aureus infections.

Conclusions:

• Emerging cell-mimicking therapeutics offer a potent strategy for eradicating intracellular bacterial infections.
• NKMs represent a promising alternative to antibiotics for treating persistent Staphylococcus aureus colonization and associated therapeutic failures.